Related Experiment Video
Updated: May 25, 2026

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites
Published on: August 8, 2014
Microbial and histopathologic considerations in the use of mouse models of inflammatory bowel diseases
Trenton R Schoeb1, Daniel C Bullard
1Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama 35294-0024, USA.
Abstract:
Mouse models provide powerful tools to investigate disease mechanisms and are widely used in inflammatory bowel disease research. However, it is common for reports of mouse model studies to lack potentially important information about the microbial status of the mice and the method used to evaluate disease expression for statistical analysis. For example, it is common practice to state that the mice were housed under specific pathogen-free conditions but provide no further information regarding the presence or absence of organisms such as Helicobacter spp. that are known or likely to affect disease expression, thus omitting information potentially important to the expected phenotype of the mice and their responses to experimental manipulation. We therefore encourage authors to use such terms as "conventional" and "specific pathogen-free" precisely, to state the agents from which the mice are represented to be free, and to provide a brief description of the health monitoring protocol. Descriptions of histopathologic methods used to evaluate colitis in mouse models also often do not include sufficient detail to allow readers to understand and evaluate the methods; in addition, the lesions commonly are shown in photomicrographs that are too small and of too low resolution to be interpreted. Inasmuch as such methods are often the major or only source of data upon which conclusions regarding genotype or experimental treatment effects are based, the method employed should be fully described, and photomicrographs should be of adequate size and resolution to allow independent assessment.
Insights
Researchers urge detailed reporting of microbial status and histopathology methods in mouse models for inflammatory bowel disease research. Clearer documentation ensures accurate interpretation of disease phenotypes and experimental outcomes.
Area of Science:
- Microbiology
- Immunology
- Animal Models
Background:
- Mouse models are crucial for studying inflammatory bowel disease (IBD).
- Current reporting often lacks critical details on mouse microbial status and disease assessment methods.
- This omission can hinder the reproducibility and interpretation of IBD research findings.
Purpose of the Study:
- To highlight the necessity for precise reporting of microbial status in mouse models.
- To emphasize the importance of detailed histopathological assessment methods in IBD research.
- To advocate for improved standards in documenting mouse models for enhanced scientific rigor.
Main Methods:
- Review of common practices in reporting mouse model studies for IBD.
- Identification of critical information gaps in current scientific literature.
- Formulation of recommendations for authors regarding microbial status and histopathology reporting.
Main Results:
- Many mouse model studies fail to specify the microbial agents (e.g., Helicobacter spp.) from which mice are considered free.
- Histopathology methods for evaluating colitis are frequently described inadequately.
- Photomicrographs used for lesion assessment are often too small or of insufficient resolution.
Conclusions:
- Precise terminology (e.g., "conventional," "specific pathogen-free") and health monitoring details are essential.
- Comprehensive descriptions of histopathology techniques and high-quality images are necessary for valid interpretation.
- Improved reporting standards will enhance the reliability and reproducibility of mouse model-based IBD research.
More Related Videos
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Inflammatory Bowel Disease III: Crohn's Disease

